cnbc
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
In this articleLLYFollow your favorite stocksCREATE FREE ACCOUNTAn injection pen of Zepbound, Eli Li ...View More
An August stocks slump is ‘absolutely normal’ — but strategists urge caution on buying the dip
A trader works on the floor of the New York Stock Exchange (NYSE) on August 1, 2024 in New York City ...View More
Ice vests, extra breaks and slushies: Olympians are struggling to keep cool in the Paris heat
Britain's Jack Draper cools himself with a bag of ice during a break in play against US' Taylor Frit ...View More
Apple is spending more on AI, but remains far behind its Silicon Valley peers
In this articleAAPLFollow your favorite stocksCREATE FREE ACCOUNTApple CEO Tim Cook opens WWDC 2024 ...View More
Microsoft says OpenAI is now a competitor in AI and search
Microsoft CEO Satya Nadella, right, greets OpenAI CEO Sam Altman during the OpenAI DevDay event in S ...View More
Meta's advertising growth is proof that hefty AI spending is already paying off
In this articleMETAFollow your favorite stocksCREATE FREE ACCOUNTMark Zuckerberg, chief executive of ...View More
Vance discusses his rocky debut and what role he wants to play as Trump's VP
Republican vice presidential nominee, U.S. Sen. JD Vance speaks at a campaign rally at Radford Unive ...View More
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
In this article4523.T-JPFollow your favorite stocksCREATE FREE ACCOUNTThe newly FDA approved Alzheim ...View More
Delta hires David Boies to seek damages from CrowdStrike, Microsoft after outage
In this articleDALCRWDFollow your favorite stocksCREATE FREE ACCOUNTDelta Air Lines has hired promin ...View More
Short seller Andrew Left surrenders on securities fraud charges in LA, due in court
Andrew Left, founder and CEO of Citron Research.Adam Jeffery | CNBCThe activist short seller Andrew ...View More
